(April 29, 2021, 2:07 PM EDT) -- NORTH CHESTERFIELD, Va. — Indivior Inc. on April 21 signed a $300 million settlement resolving claims by all 50 states, the District of Columbia and the Commonwealth of Puerto Rico that Indivior promoted the opioid withdrawal treatment drug Suboxone for off-label use, falsely claimed that Suboxone was less subject to diversion and falsely claimed that Suboxone tablets were discontinued for “safety concerns.”...